Use of neridronic acid or of its salt for the treatment of osteoarthrosis
Номер патента: NZ730853A
Опубликовано: 29-06-2018
Автор(ы): Varenna Massimo
Принадлежит: Abiogen Pharma Spa
Опубликовано: 29-06-2018
Автор(ы): Varenna Massimo
Принадлежит: Abiogen Pharma Spa
Реферат: The use of neridronic acid or a salt thereof in the treatment of osteoarthritis is described. In particular, neridronic acid or a salt thereof has been shown to be able to reduce significantly the symptoms of osteoarthritis, such as pain and physical and mobility disabilities, as well as subchondral bone marrow lesions underlying the onset of such symptoms.
Topical oral and/or systemic oral formulations containing a mixture based on lactoferrin, more efficacious in iron uptake, for the prevention and treatment of several pathologies
Номер патента: EP3946430A1. Автор: Piera Valenti,Rosalba Paesano. Владелец: Uragme Srl. Дата публикации: 2022-02-09.